Question Bank › Constraint-side candor

Constraint-side candor

Constraint-side candor: management freely details what it cannot yet do while demand is not the question

Calls Tested
500
Answered YES
31
Hit Rate
6.2%
rare by design

Sociedad Química y Minera de Chile S.A. (SQM) — this company's answers

NO on the Q1 2022 call 2022-05-19 C+
The model's full reasoning — Q1 2022 call → NO我们根据提供的电话会议记录来判断。管理层是否自愿且具体地详细说明了公司自身的当前限制，同时明确表示对其所售产品的需求不是问题，并将这种坦诚与已经进行的实际补救措施相结合。 检查记录内容： - 管理层提到了锂、碘、硝酸盐等业务。关于锂，他们提到“我们正在按目标达到180,000公吨，计划达到210,000公吨和40,000公吨的碳酸锂和氢氧化锂产能，进展顺利。”这暗示了产能扩张，但并未明确说当前无法满足需求。 - 关于碘，他们提到“我们仍按目标在明年增加1,000公吨产能，2024年增加2,500公吨。”同样，这是扩张计划。 - 关于硝酸盐，他们提到“增加320,000公吨产能”。 - 在回答关于中国封锁的问题时，他们提到“在4月份，由于上海封锁，我们的销售有所下降。在5月份，我们看到需求正在恢复，因此我们预计将开始赶上销售。在第二季度，销量可能会低于第一季度。”这提到了由于封锁导致的销售下降，但这是外部因素，不是公司自身的限制。 - 关于锂的定价，他们提到“大约50%的销售以完全可变价格指数签约，约30%的销售仍开放，约20%有上限。”这没有提到无法满足需求。 - 关于成本，他们提到“我们正在努力控制成本”。 - 关于产能，他们提到“我们正在努力达到180,000公吨，计划达到210,000公吨”，但这是未来目标，不是当前限制。 - 在回答关于投资的问题时，他们提到“我们正在审查投资计划，可能会增加资源”，但未具体说明当前无法做什么。 管理层是否自愿且具体地说明了公司自身的当前限制？他们提到了产能扩张计划，但并未明确说“我们目前无法满足需求”或“我们缺少产能”等。他们提到第二季度销量可能低于第一季度，但原因是封锁，不是公司自身能力不足。他们也没有提到无法填补的职位或未准备好的系统。 关于需求，他们提到“需求基本面仍然存在”，但未明确说需求是当前且已确定的。他们提到“我们预计销量将在140,000公吨左右”，但这是预测，不是已确认的订单。 关于补救措施，他们提到了扩张计划，但这是计划，不是“正在执行”的具体工作。他们提到“我们正在努力达到180,000公吨”，但未详细说明具体步骤。 因此，管理层没有自愿且具体地详细说明公司自身的当前限制，也没有明确表示需求是当前且已确定的，也没有描述正在执行的补救措施。他们更多是谈论增长计划和市场状况。 所以答案应为NO。

← Back to the full SQM analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management VOLUNTARILY AND SPECIFICALLY DETAIL THE COMPANY'S OWN CURRENT LIMITATIONS — what it cannot yet produce, serve, staff, deliver, or handle — while making clear that DEMAND FOR WHAT IT SELLS IS NOT THE PROBLEM, and does management pair that candor with real remediation already underway? Answer YES when management's own account conveys, in whatever form fits the business, ONE coherent posture with all three present: (1) SPECIFIC SELF-IDENTIFIED LIMITS: management itself names concrete things the company currently cannot do or cannot do enough of — capacity it lacks, roles it cannot fill fast enough, systems or facilities not yet ready, output it cannot yet reach, orders it cannot yet serve — described plainly and unprompted rather than extracted defensively; (2) DEMAND TREATED AS PRESENT AND SETTLED: the business the company cannot fully serve is real and current (orders, customers, committed work, or arriving volume already in hand), so the limits are binding against actual business rather than hypothetical growth; and (3) FIXES IN MOTION: management describes the specific work already underway to remove each named limit — building, hiring, commissioning, qualifying — as executing now, not planned. The candor itself is the signal: management speaking like operators cataloguing bottlenecks rather than promoters selling a story. Answer NO if the limitations discussed are excuses for weak demand, competitive losses, or macro softness. NO if the constraints are shortages of purchased inputs with no unserved business of the company's own behind them. NO if management describes limits but no remediation already executing. NO if the discussion is generic ('we are capacity constrained', 'we are investing in growth') without named specific limits. NO if the company is comfortably serving everything asked of it. NO if the posture appears only in analyst questions management does not engage substantively. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
NOAH Noah Holdings Limited Q1 2024 2024-05-30 D
ROCK Gibraltar Industries, Inc. Q1 2024 2024-05-01 B+
GIII G-III Apparel Group, Ltd. Q4 2024 2024-03-14 C
BRBR BellRing Brands, Inc. Q4 2023 2023-11-21 B+
GOLD Barrick Gold Corporation Q3 2023 2023-11-02 C
CMG Chipotle Mexican Grill, Inc. Q3 2023 2023-10-27 B+
PRPH ProPhase Labs, Inc. Q1 2023 2023-05-11 F
TSSI TSS, Inc. Q4 2022 2023-04-03 D
TACT TransAct Technologies Incorporated Q4 2022 2023-03-08 A
PI Impinj, Inc. Q4 2022 2023-02-08 B+
CEIX CONSOL Energy Inc. Q4 2022 2023-02-07 B
SIBN SI-BONE, Inc. Q3 2022 2022-11-07 C+
CHE Chemed Corporation Q3 2022 2022-11-01 B+
CRL Charles River Laboratories International Q2 2022 2022-08-03 C
JBHT J.B. Hunt Transport Services, Inc. Q2 2022 2022-07-19 C+
OGI OrganiGram Holdings Inc. Q3 2022 2022-07-14 B+
FLUX Flux Power Holdings, Inc. Q2 2022 2022-02-10 D
GTES Gates Industrial Corporation plc Q4 2021 2022-02-07 C+
FORM FormFactor, Inc. Q4 2021 2022-02-02 B
GFS GLOBALFOUNDRIES Inc. Q3 2021 2021-11-30 A
HNRG Hallador Energy Company Q3 2021 2021-11-09 C+
HY Hyster-Yale Materials Handling, Inc. Q3 2021 2021-11-06 D
EMR Emerson Electric Co. Q3 2021 2021-08-04 B+
PRIM Primoris Services Corporation Q2 2018 2018-08-11 C+
FSS Federal Signal Corporation Q1 2018 2018-05-12 A
ACHC Acadia Healthcare Company, Inc. Q4 2017 2018-02-22 C+
AOSL Alpha and Omega Semiconductor Limited Q2 2018 2018-02-07 B
HOLX Hologic, Inc. Q4 2017 2017-11-08 D
ZBH Zimmer Biomet Holdings, Inc. Q2 2017 2017-07-30 F
PLAB Photronics, Inc. Q2 2017 2017-05-17 C+
PPG PPG Industries, Inc. Q1 2017 2017-04-20 C

How the model reasoned

HY · Q3 2021 → YESThe question is: Does management voluntarily and specifically detail the company's own current limitations — what it cannot yet produce, serve, staff, deliver, or handle — while making clear that dema...NO The transcript shows management identifying specific constraints around component shortages and supply chain issues that are limiting production and shipping, with record backlog indicating real demand. However, these limitations are framed as shortages of purchased inputs (components and logistics), which the question explicitly excludes from consideration. The remediation efforts mentioned (expanding teams to secure components) are underway, but the core issue is input constraints rather than the company's own production or operational limits. The candor is present, but it doesn't meet the full criteria for "company's own current limitations" as defined.
CEIX · Q4 2022 → YESThe question is: Does management voluntarily and specifically detail the company's own current limitations — what it cannot yet produce, serve, staff, deliver, or handle — while making clear that dema...YES Management voluntarily details specific self-identified limits (staffing challenges preventing full staffing and optimization of CM super sections, supply chain and equipment delays, geological issues) unprompted. Demand is treated as present and settled through actual sales and marketing of coal, with the Itmann project ramp-up delayed despite committed production. Fixes are already in motion via recent changes, focus on staffing two sections, and transition to operations team oversight. This forms a coherent posture of candid bottleneck cataloguing paired with executing remediation.
ACHC · Q4 2017 → YESThe question is: Does management voluntarily and specifically detail the company's own current limitations — what it cannot yet produce, serve, staff, deliver, or handle — while making clear that dema...NO The transcript shows management addressing UK-specific constraints (nurse shortages, retrofitting beds, NHS transition delays) and noting real demand elements like census and community needs. However, it does not clearly convey a coherent posture where demand is explicitly treated as settled and unproblematic, with remediation already executing in a specific, 1-2-3 format. The discussion leans more toward operational challenges tied to external factors like NHS processes rather than purely internal limits paired with active fixes. Thus, it does not fully meet the criteria for a YES.

More from the question bank

Physical throughput records at the operatingThe economics improved before the volume arrSmall reported base, oversized already-contrNamed counterparty roster suddenly upgraded Repeat expansion inside the base while new lGeographic or market replication just starteAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.